Verastem price target lowered to $13 from $14 at Mizuho Securities
Upside remains since target still above current price.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside remains since target still above current price.
What happened, with direct paths to the underlying reporting
Mizuho Securities lowers VSTM price target to $13 from $14; current price is $6.51.
Target: $13
Posted price: $6.51
Analyst firm: Mizuho Securities
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.